Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion

Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion

Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion

  • Home
  • The Weekly Rap
  • Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion

Covid-19 vaccine developer AstraZeneca agrees to buy rare disease firm Alexion for $39 billion

By Shannon Liao, CNN Business Leading Covid-19 vaccine developer AstraZeneca agreed on Saturday to buy Boston pharmaceutical firm Alexion for $39 billion.

 

More Episodes

Actress Christina Ricci has been granted a restraining order against her estranged husband, James Heerdegen, whom she is accusing…
Netflix announced on Thursday that Bridgerton is officially coming back for season 2.  The series, based on a series of…
By Annie Grayer, CNN US Capitol Police are investigating an incident in which a Republican lawmaker was stopped from…
By Caroline Kelly, CNN The Justice Department inspector general is investigating the sudden departure of former Atlanta US Attorney…
Loading...